Verapamil Hydrochloride Injection - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Verapamil Hydrochloride Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Verapamil Hydrochloride Injection Market Restraints
Table 3. Verapamil Hydrochloride Injection Market Trends
Table 4. Verapamil Hydrochloride Injection Industry Policy
Table 5. Global Verapamil Hydrochloride Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Verapamil Hydrochloride Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Verapamil Hydrochloride Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Verapamil Hydrochloride Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Verapamil Hydrochloride Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Verapamil Hydrochloride Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Verapamil Hydrochloride Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Verapamil Hydrochloride Injection Manufacturers Product Type
Table 13. Head Office and Verapamil Hydrochloride Injection Production Site of Key Manufacturer
Table 14. Verapamil Hydrochloride Injection Capacity of Major Manufacturers and Future Plan
Table 15. China Verapamil Hydrochloride Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Verapamil Hydrochloride Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Verapamil Hydrochloride Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Verapamil Hydrochloride Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Verapamil Hydrochloride Injection Production by Region, 2018-2023, (K Units)
Table 20. Global Verapamil Hydrochloride Injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Verapamil Hydrochloride Injection Upstream (Raw Materials)
Table 22. Global Verapamil Hydrochloride Injection Typical Customers
Table 23. Verapamil Hydrochloride Injection Typical Distributors
Table 24. By Type, Global Verapamil Hydrochloride Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Verapamil Hydrochloride Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Verapamil Hydrochloride Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Verapamil Hydrochloride Injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Verapamil Hydrochloride Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Verapamil Hydrochloride Injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Verapamil Hydrochloride Injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Verapamil Hydrochloride Injection Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 36. Pfizer Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Exela Pharma Company Information, Head Office, Market Area, and Industry Position
Table 40. Exela Pharma Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 41. Exela Pharma Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Exela Pharma Company Profile and Main Business
Table 43. Exela Pharma Recent Developments
Table 44. Mankind Pharma Company Information, Head Office, Market Area, and Industry Position
Table 45. Mankind Pharma Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 46. Mankind Pharma Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Mankind Pharma Company Profile and Main Business
Table 48. Mankind Pharma Recent Developments
Table 49. ACIC Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 50. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 51. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. ACIC Pharmaceuticals Company Profile and Main Business
Table 53. ACIC Pharmaceuticals Recent Developments
Table 54. Zydus Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 55. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 56. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Zydus Pharmaceuticals Company Profile and Main Business
Table 58. Zydus Pharmaceuticals Recent Developments
Table 59. Gland Pharma Company Information, Head Office, Market Area, and Industry Position
Table 60. Gland Pharma Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 61. Gland Pharma Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Gland Pharma Company Profile and Main Business
Table 63. Gland Pharma Recent Developments
Table 64. China Res Double-Crane Company Information, Head Office, Market Area, and Industry Position
Table 65. China Res Double-Crane Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 66. China Res Double-Crane Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. China Res Double-Crane Company Profile and Main Business
Table 68. China Res Double-Crane Recent Developments
Table 69. Shiyao YINHU Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 71. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Shiyao YINHU Pharmaceutical Company Profile and Main Business
Table 73. Shiyao YINHU Pharmaceutical Recent Developments
Table 74. Jilin Jinsheng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 76. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Jilin Jinsheng Pharmaceutical Company Profile and Main Business
Table 78. Jilin Jinsheng Pharmaceutical Recent Developments
Table 79. Shanghai Harvest Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 81. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Shanghai Harvest Pharmaceutical Company Profile and Main Business
Table 83. Shanghai Harvest Pharmaceutical Recent Developments
Table 84. Jiangsu Langou Drug Company Information, Head Office, Market Area, and Industry Position
Table 85. Jiangsu Langou Drug Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 86. Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Jiangsu Langou Drug Company Profile and Main Business
Table 88. Jiangsu Langou Drug Recent Developments
Table 89. Jiangsu Ruinian Qianjin Pharmacy Company Information, Head Office, Market Area, and Industry Position
Table 90. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 91. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Jiangsu Ruinian Qianjin Pharmacy Company Profile and Main Business
Table 93. Jiangsu Ruinian Qianjin Pharmacy Recent Developments
Table 94. Chongqing Yaoyou Pharmacy Company Information, Head Office, Market Area, and Industry Position
Table 95. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 96. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Chongqing Yaoyou Pharmacy Company Profile and Main Business
Table 98. Chongqing Yaoyou Pharmacy Recent Developments
Table 99. Hubei Weishi Company Information, Head Office, Market Area, and Industry Position
Table 100. Hubei Weishi Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 101. Hubei Weishi Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Hubei Weishi Company Profile and Main Business
Table 103. Hubei Weishi Recent Developments
Table 104. Duoduo Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 106. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Duoduo Pharmaceutical Company Profile and Main Business
Table 108. Duoduo Pharmaceutical Recent Developments
Table 109. Harbin Pharm. Group Sanjing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 111. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Harbin Pharm. Group Sanjing Pharmaceutical Company Profile and Main Business
Table 113. Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments
Table 114. Chia Tai-Tianqing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 115. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Models, Specifications, and Application
Table 116. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Chia Tai-Tianqing Pharmaceutical Company Profile and Main Business
Table 118. Chia Tai-Tianqing Pharmaceutical Recent Developments
List of Figures
Figure 1. Verapamil Hydrochloride Injection Picture
Figure 2. Global Verapamil Hydrochloride Injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Verapamil Hydrochloride Injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Verapamil Hydrochloride Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Verapamil Hydrochloride Injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Verapamil Hydrochloride Injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Verapamil Hydrochloride Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Verapamil Hydrochloride Injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Verapamil Hydrochloride Injection Market Share of Global, 2018-2029
Figure 10. Global Verapamil Hydrochloride Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Verapamil Hydrochloride Injection Key Participants, Market Share, 2022
Figure 12. Global Verapamil Hydrochloride Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Verapamil Hydrochloride Injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Verapamil Hydrochloride Injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Verapamil Hydrochloride Injection Industry Chain
Figure 16. Verapamil Hydrochloride Injection Procurement Model
Figure 17. Verapamil Hydrochloride Injection Sales Model
Figure 18. Verapamil Hydrochloride Injection Sales Channels, Direct Sales, and Distribution
Figure 19. Oral
Figure 20. Intravenous Injection
Figure 21. By Type, Global Verapamil Hydrochloride Injection Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Verapamil Hydrochloride Injection Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Verapamil Hydrochloride Injection Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Verapamil Hydrochloride Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinics
Figure 28. Other
Figure 29. By Application, Global Verapamil Hydrochloride Injection Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Verapamil Hydrochloride Injection Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Verapamil Hydrochloride Injection Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Verapamil Hydrochloride Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Verapamil Hydrochloride Injection Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Verapamil Hydrochloride Injection Sales Quantity Market Share, 2018-2029
Figure 36. North America Verapamil Hydrochloride Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Verapamil Hydrochloride Injection Consumption Value Market Share, 2022
Figure 38. Europe Verapamil Hydrochloride Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Verapamil Hydrochloride Injection Consumption Value Market Share, 2022
Figure 40. Asia Pacific Verapamil Hydrochloride Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Verapamil Hydrochloride Injection Consumption Value Market Share, 2022
Figure 42. South America Verapamil Hydrochloride Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Verapamil Hydrochloride Injection Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Verapamil Hydrochloride Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Verapamil Hydrochloride Injection Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Verapamil Hydrochloride Injection Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets